# KCNH2‐L693P Causes Long QT Syndrome Type 2 Through hERG Channel Dysfunction: Functional Validation of a Variant of Uncertain Significance

**Authors:** Xi‐Fan Zheng, Qiu Chen, Xiang‐Ting Lu, Hai‐Long Dai, Xue‐Feng Guang

PMC · DOI: 10.1002/mgg3.70155 · Molecular Genetics & Genomic Medicine · 2025-11-17

## TL;DR

This study shows that the KCNH2-L693P mutation causes a heart condition by disrupting potassium channel function, helping reclassify it from uncertain to harmful.

## Contribution

The study provides functional validation of the KCNH2-L693P variant as pathogenic in LQTS2.

## Key findings

- The L693P mutation causes trafficking defects and reduced mature hERG protein levels.
- The mutation leads to complete current loss in homozygotes and partial suppression in heterozygotes.
- It alters steady-state inactivation and delays recovery of hERG channels.

## Abstract

Congenital long QT syndrome (LQTS) is an inherited arrhythmia characterized by QT prolongation and increased risk of ventricular arrhythmias. Type 2 LQTS (LQT2) results from mutations in the KCNH2 gene encoding the hERG potassium channel. With the widespread use of next‐generation sequencing, many KCNH2 variants have been identified but remain classified as variants of uncertain significance (VUS), including p.L693P, requiring functional validation.

A proband with recurrent syncope and prolonged QTc underwent whole‐exome and family‐based Sanger sequencing, which detected a heterozygous KCNH2‐L693P mutation. HEK293 cells were transiently transfected with wild‐type (WT) and/or mutant hERG plasmids. Western blotting, immunofluorescence, and whole‐cell patch clamp were performed to assess protein maturation, trafficking, and channel kinetics.

Western blot showed reduced levels of the 155 kDa mature hERG and accumulation of the 135 kDa immature form, consistent with trafficking defects. Immunofluorescence confirmed endoplasmic reticulum (ER) retention. Electrophysiology revealed complete current loss in homozygotes and ~39% residual WT current in heterozygotes, indicating dominant‐negative‐like suppression. The mutation shifted steady‐state inactivation and delayed recovery.

The KCNH2‐L693P mutation impairs hERG maturation and function, supporting its reclassification from variants of uncertain significance (VUS) to pathogenic and providing evidence for improved clinical management.

This study functionally confirmed the pathogenicity of the KCNH2 missense variant L693P, previously classified as a variant of uncertain significance, which causes type 2 congenital long QT syndrome by impairing potassium channel maturation and altering inactivation kinetics.

## Linked entities

- **Genes:** KCNH2 (potassium voltage-gated channel subfamily H member 2) [NCBI Gene 3757]
- **Proteins:** KCNH2 (potassium voltage-gated channel subfamily H member 2)
- **Diseases:** long QT syndrome (MONDO:0002442)

## Full-text entities

- **Genes:** KCNH2 (potassium voltage-gated channel subfamily H member 2) [NCBI Gene 3757] {aka ERG-1, ERG1, H-ERG, HERG, HERG1, Kv11.1}
- **Diseases:** Congenital long QT syndrome (MESH:D008133), inherited arrhythmia (MESH:D001145), syncope (MESH:D013575), LQT2 (MESH:C563614)
- **Mutations:** L693P
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12620996/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12620996/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12620996/full.md

---
Source: https://tomesphere.com/paper/PMC12620996